INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.

Go back to INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High
Open $1.41    52 Week Low
Day High $1.48    P/E N/A 
Day Low $1.35    EPS
Volume 284,421       

(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High
Open $1.41    52 Week Low
Day High $1.48    P/E N/A 
Day Low $1.35    EPS
Volume 284,421